Access cutting-edge breast cancer treatment through this clinical trial at a research site in Kingman. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Kingman at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observa
Sponsor: Alliance for Clinical Trials in Oncology
Check if you qualify for this breast cancer clinical trial in Kingman, AZ
If you're searching for breast cancer treatment options in Kingman, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kingman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.